Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CCR1 | P32246 | 1/20 | 0.32 |
| ▸ | CCR5 | P51681 | 1/20 | 0.32 |
| ▸ | CCR8 | P51685 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | NQO1 | P15559 | 1/20 | 0.30 |
| ▸ | POR | P16435 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28328895 | 0.84 | OPRK1 (0.41) | CYP1A2ESR1ESR2TSHRALDH1A1 | |
| SCHEMBL8404429 | 0.73 | TSHR (0.48) | CYP1A2CYP2A6TSHRALDH1A1TDP1 | |
| SCHEMBL3871139 | 0.73 | CYP2A6 (0.52) | CYP1A2CYP2A6TSHRALDH1A1TDP1 | |
| SCHEMBL426079 | 0.70 | — | — | |
| SCHEMBL14299138 | 0.68 | CCR1 (0.33) | CCR1CCR5CCR8 | |
| SCHEMBL31001023 | 0.67 | CYP1A2 (0.56) | CYP1A2CYP2A6TSHRALDH1A1TDP1 | |
| SCHEMBL5156814 | 0.65 | — | — | |
| SCHEMBL31073495 | 0.65 | MEN1 (0.32) | KMT2A | |
| SCHEMBL601246 | 0.65 | CYP1A2 (0.53) | CYP1A2CYP2A6TSHRALDH1A1TDP1 | |
| SCHEMBL161370 | 0.65 | CYP1A2 (1.00) | CYP1A2CYP2A6TSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114920911-B | Method for producing polyisothiaindene conductive polymer | 株式会社力森诺科 | 2024-05-03 | — | — | CN | disclosed |
| CN-114920911-A | Method for producing polyisothianaphthene-based conductive polymer | 昭和电工株式会社 | 2022-08-19 | — | — | CN | disclosed |
| CN-110121516-B | Method for producing polyisothianaphthene-based conductive polymer | 昭和电工株式会社 | 2022-07-01 | — | — | CN | disclosed |
| US-11183340-B2 | Method for manufacturing solid electrolytic capacitor | SHOWA DENKO K.K. (JP) | 2021-11-23 | — | — | US | disclosed |
| US-11136432-B2 | Method for producing polyisothianaphthene-based electroconductive polymer | SHOWA DENKO K.K. (JP) | 2021-10-05 | — | — | US | disclosed |
| CN-110121757-B | Method for manufacturing solid electrolytic capacitor | 昭和电工株式会社 | 2021-09-14 | — | — | CN | disclosed |
| US-20200090874-A1 | METHOD FOR MANUFACTURING SOLID ELECTROLYTIC CAPACITOR | SHOWA DENKO K.K. (JP) | 2020-03-19 | — | — | US | disclosed |
| US-20190345287-A1 | METHOD FOR PRODUCING POLYISOTHIANAPHTHENE-BASED ELECTROCONDUCTIVE POLYMER | SHOWA DENKO K.K. (JP) | 2019-11-14 | — | — | US | disclosed |
| EP-3564290-A1 | METHOD FOR PRODUCING POLYISOTHIANAPHTHENE ELECTROCONDUCTIVE POLYMER | Showa Denko K.K. (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-3564976-A1 | METHOD FOR MANUFACTURING SOLID ELECTROLYTIC CAPACITOR | Showa Denko K.K. (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-20100266556-A1 | METHOD FOR EXPANDING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20100127220-A1 | Process for Preparing Substituted Pentacenes | MERCK PATENT GMBH (DE) | 2010-05-27 | — | — | US | disclosed |
| US-20100127220-A1 | Process for Preparing Substituted Pentacenes | MERCK PATENT GMBH (DE) | 2010-05-27 | — | — | US | disclosed |
| US-20100127220-A1 | Process for Preparing Substituted Pentacenes | MERCK PATENT GMBH (DE) | 2010-05-27 | — | — | US | disclosed |
| CN-101663309-A | Process for preparing substituted pentacenes | MERCK PATENT GMBH | 2010-03-03 | — | — | CN | disclosed |
| EP-2134725-A1 | PROCESS FOR PREPARING SUBSTITUTED PENTACENES | Merck Patent GmbH (DE) | 2009-12-23 | — | — | EP | disclosed |
| WO-2008128618-A1 | PROCESS FOR PREPARING SUBSTITUTED PENTACENES | MERCK PATENT GMBH (DE) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008128618-A1 | PROCESS FOR PREPARING SUBSTITUTED PENTACENES | MERCK PATENT GMBH (DE) | 2008-10-30 | — | — | WO | disclosed |
| WO-2007043675-A9 | COMPOSITION FOR CONDUCTIVE MATERIALS, CONDUCTIVE MATERIAL, CONDUCTIVE LAYER, ELECTRONIC DEVICE, AND ELECTRONIC EQUIPMENT | SEIKO EPSON CORP (JP) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007010880-A1 | LIGHT EMITTING DEVICE AND ELECTRONIC EQUIPMENT PROVIDED WITH THE LIGHT EMITTING DEVICE | SEIKO EPSON CORPORATION (JP) | 2007-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266556-A1 | METHOD FOR EXPANDING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | HCLS1, RUNX1, ACIN1 | CYP1A2 2808/4885CYP2A6 2755/4885ESR1 3366/4885 |
| US-20100127220-A1 | Process for Preparing Substituted Pentacenes | FES, PFAS, SLC46A1 | CYP1A2 1513/4885CYP2A6 3116/4885ESR1 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.